These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 10716151)
1. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Nelson BP; Nalesnik MA; Bahler DW; Locker J; Fung JJ; Swerdlow SH Am J Surg Pathol; 2000 Mar; 24(3):375-85. PubMed ID: 10716151 [TBL] [Abstract][Full Text] [Related]
2. Role of Epstein-Barr virus status and immunophenotypic studies in the evaluation of exfoliative cytology specimens from patients with post-transplant lymphoproliferative disorders. Gibson SE; Picarsic J; Swerdlow SH; Pantanowitz L Cancer Cytopathol; 2016 Jun; 124(6):425-35. PubMed ID: 26992116 [TBL] [Abstract][Full Text] [Related]
3. Characteristic pattern of chromosomal imbalances in posttransplantation lymphoproliferative disorders: correlation with histopathological subcategories and EBV status. Poirel HA; Bernheim A; Schneider A; Meddeb M; Choquet S; Leblond V; Charlotte F; Davi F; Canioni D; Macintyre E; Mamzer-Bruneel MF; Hirsch I; Hermine O; Martin A; Cornillet-Lefebvre P; Patey M; Toupance O; Kémény JL; Deteix P; Raphaël M Transplantation; 2005 Jul; 80(2):176-84. PubMed ID: 16041261 [TBL] [Abstract][Full Text] [Related]
4. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study. Johnson LR; Nalesnik MA; Swerdlow SH Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518 [TBL] [Abstract][Full Text] [Related]
5. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? Leblond V; Davi F; Charlotte F; Dorent R; Bitker MO; Sutton L; Gandjbakhch I; Binet JL; Raphael M J Clin Oncol; 1998 Jun; 16(6):2052-9. PubMed ID: 9626203 [TBL] [Abstract][Full Text] [Related]
9. Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder. Picarsic J; Jaffe R; Mazariegos G; Webber SA; Ellis D; Green MD; Reyes-Múgica M Cancer; 2011 Oct; 117(19):4540-50. PubMed ID: 21446044 [TBL] [Abstract][Full Text] [Related]
10. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases]. Chen DB; Wang Y; Song QJ; Shen DH Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829 [TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients. Capello D; Rasi S; Oreste P; Veronese S; Cerri M; Ravelli E; Rossi D; Minola E; Colosimo A; Gambacorta M; Muti G; Morra E; Gaidano G J Pathol; 2009 Aug; 218(4):478-86. PubMed ID: 19391128 [TBL] [Abstract][Full Text] [Related]
12. Posttransplant lymphoproliferative disorders in lung transplant patients: the Cleveland Clinic experience. Ramalingam P; Rybicki L; Smith MD; Abrahams NA; Tubbs RR; Pettay J; Farver CF; Hsi ED Mod Pathol; 2002 Jun; 15(6):647-56. PubMed ID: 12065779 [TBL] [Abstract][Full Text] [Related]
13. EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient. Yin CC; Medeiros LJ; Abruzzo LV; Jones D; Farhood AI; Thomazy VA Am J Clin Pathol; 2005 Feb; 123(2):222-8. PubMed ID: 15842046 [TBL] [Abstract][Full Text] [Related]
18. Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus. Lones MA; Shintaku IP; Weiss LM; Thung SN; Nichols WS; Geller SA Hum Pathol; 1997 May; 28(5):533-9. PubMed ID: 9158700 [TBL] [Abstract][Full Text] [Related]
19. Significance of in situ hybridization results for EBV-encoded RNA in post-transplantation lymphoproliferative disorder setting: report from the PTLD.Int Survey. Izadi M; Taheri S Ann Transplant; 2010; 15(4):102-9. PubMed ID: 21183884 [TBL] [Abstract][Full Text] [Related]